Heritage Investors Management Corp raised its stake in shares of Johnson & Johnson (NYSE:JNJ) by 0.0% during the third quarter, Holdings Channel reports. The institutional investor owned 171,537 shares of the company’s stock after buying an additional 73 shares during the period. Johnson & Johnson accounts for approximately 1.5% of Heritage Investors Management Corp’s investment portfolio, making the stock its 14th largest position. Heritage Investors Management Corp’s holdings in Johnson & Johnson were worth $20,264,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the stock. NN Investment Partners Holdings N.V. acquired a new position in shares of Johnson & Johnson during the first quarter valued at $92,331,000. Adell Harriman & Carpenter Inc. raised its position in shares of Johnson & Johnson by 5.4% in the first quarter. Adell Harriman & Carpenter Inc. now owns 83,918 shares of the company’s stock valued at $9,080,000 after buying an additional 4,292 shares in the last quarter. Canandaigua National Bank & Trust Co. raised its position in shares of Johnson & Johnson by 0.3% in the first quarter. Canandaigua National Bank & Trust Co. now owns 97,516 shares of the company’s stock valued at $10,551,000 after buying an additional 291 shares in the last quarter. Royal Bank of Scotland Group PLC raised its position in shares of Johnson & Johnson by 1.7% in the first quarter. Royal Bank of Scotland Group PLC now owns 10,950 shares of the company’s stock valued at $1,184,000 after buying an additional 182 shares in the last quarter. Finally, USS Investment Management Ltd raised its position in shares of Johnson & Johnson by 38.9% in the first quarter. USS Investment Management Ltd now owns 211,814 shares of the company’s stock valued at $22,913,000 after buying an additional 59,314 shares in the last quarter. Institutional investors and hedge funds own 64.13% of the company’s stock.

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) traded down 0.54% during mid-day trading on Tuesday, hitting $112.52. 2,476,196 shares of the stock were exchanged. Johnson & Johnson has a 52 week low of $94.28 and a 52 week high of $126.07. The company has a market capitalization of $306.11 billion, a PE ratio of 19.75 and a beta of 0.75. The stock’s 50-day moving average is $115.97 and its 200 day moving average is $118.40.

Johnson & Johnson (NYSE:JNJ) last posted its earnings results on Tuesday, October 18th. The company reported $1.68 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.66 by $0.02. Johnson & Johnson had a net margin of 22.03% and a return on equity of 25.30%. The firm earned $17.80 billion during the quarter, compared to analyst estimates of $17.71 billion. During the same quarter in the prior year, the business posted $1.49 EPS. The business’s revenue was up 4.2% compared to the same quarter last year. On average, analysts anticipate that Johnson & Johnson will post $6.72 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 6th. Stockholders of record on Tuesday, November 22nd will be paid a $0.80 dividend. This is a positive change from Johnson & Johnson’s previous quarterly dividend of $0.29. The ex-dividend date of this dividend is Friday, November 18th. This represents a $3.20 annualized dividend and a dividend yield of 2.83%. Johnson & Johnson’s dividend payout ratio is presently 56.64%.

ILLEGAL ACTIVITY NOTICE: “Heritage Investors Management Corp Has $20,264,000 Position in Johnson & Johnson (JNJ)” was posted by Financial Market News and is the propert of of Financial Market News. If you are viewing this report on another publication, it was copied illegally and republished in violation of international copyright & trademark legislation. The legal version of this report can be read at http://www.financial-market-news.com/heritage-investors-management-corp-has-20264000-position-in-johnson-johnson-jnj/1208531/.

Several equities research analysts have weighed in on the stock. Argus reiterated a “buy” rating and issued a $145.00 target price on shares of Johnson & Johnson in a report on Friday, October 21st. Barclays PLC lowered shares of Johnson & Johnson from an “overweight” rating to an “equal weight” rating and increased their target price for the stock from $113.13 to $125.00 in a report on Tuesday. They noted that the move was a valuation call. Vetr lowered shares of Johnson & Johnson from a “buy” rating to a “hold” rating and set a $119.60 target price on the stock. in a report on Tuesday, November 1st. Leerink Swann reiterated a “buy” rating on shares of Johnson & Johnson in a report on Sunday, September 11th. Finally, Jefferies Group increased their target price on shares of Johnson & Johnson from $113.00 to $119.00 and gave the stock a “hold” rating in a report on Thursday, August 4th. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and eight have issued a buy rating to the stock. Johnson & Johnson presently has a consensus rating of “Hold” and a consensus target price of $121.02.

In other news, Director Charles Prince bought 875 shares of Johnson & Johnson stock in a transaction dated Friday, October 21st. The stock was purchased at an average price of $114.11 per share, for a total transaction of $99,846.25. Following the purchase, the director now directly owns 26,520 shares in the company, valued at approximately $3,026,197.20. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.11% of the stock is currently owned by insiders.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company’s segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women’s health and wound care markets.

5 Day Chart for NYSE:JNJ

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.